+152.4%
MRNA vs GGLL
+120.8%
+31.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GGLL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -6.9% | +8.2% | +2.6% |
| 7D | -13.8% | -17.1% | +3.3% | -10.7% |
| 30D | -17.7% | -38.1% | +20.4% | -10.6% |
| 3M | +14.3% | -41.2% | +55.5% | +25.4% |
| 6M | +336.0% | -56.2% | +392.2% | +400.8% |
| YTD | +575.9% | -37.2% | +613.2% | +617.4% |
| 1Y | +724.4% | -29.8% | +754.1% | +756.8% |
| All | +152.4% | +120.8% | +31.6% | +123.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GGLL.
Daily Out/Under-Performance
Portfolio return minus GGLL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GGLL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GGLL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling